Abstract

Nicotinamide-N-methyltransferase (NNMT) is a cytosolic enzyme catalyzing the transfer of a methyl group from S-adenosyl-methionine (SAM) to nicotinamide (Nam). It is expressed in many tissues including the liver, adipose tissue, and skeletal muscle. Its expression in several cancer cell lines has been widely discussed in the literature, and recent work established a link between NNMT expression and metabolic diseases. Here we describe our approach to identify potent small molecule inhibitors of NNMT featuring different binding modes as elucidated by X-ray crystallographic studies.

Highlights

  • Nicotinamide-N-methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the transfer of a methyl group from S-adenosyl-methionine (SAM) to nicotinamide (Nam), yielding S-adenosyl-homocysteine (SAH) and 1-methylnicotinamide (MNam) [1,2]

  • The binding mode of these inhibitors has been elucidated by X-ray crystallography and we used this information for the design of the novel inhibitors (33)

  • Our bisubstrate inhibitors posed a significant challenge for optimization towards acceptable metabolic stabilities while maintaining sufficient in vitro inhibitory potency

Read more

Summary

Introduction

Nicotinamide-N-methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the transfer of a methyl group from S-adenosyl-methionine (SAM) to nicotinamide (Nam), yielding S-adenosyl-homocysteine (SAH) and 1-methylnicotinamide (MNam) [1,2]. It is expressed in most tissues including the liver, adipose tissue, and skeletal muscle [3], and in several human cancers [4]. Interventions to improve metabolic health such as exercise and bariatric surgery were shown to decrease adipose NNMT expression and plasma MNam levels in obese individuals with insulin resistance or T2D [10]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.